Results 191 to 200 of about 616,391 (245)

Application of NMRK immobilized enzymes in the synthesis of NMN. [PDF]

PLoS One
Yang S, Xiang T, Qian J, Sun W, Liu W, Yi N, Qin ZH.   +6 more
europepmc   +1 more source

BMI‐1 modulation and trafficking during M phase in diffuse intrinsic pontine glioma

FEBS Open Bio, EarlyView.
The schematic illustrates BMI‐1 phosphorylation during M phase, which triggers its translocation from the nucleus to the cytoplasm. In cycling cells, BMI‐1 functions within the PRC1 complex to mediate H2A K119 monoubiquitination. Following PTC596‐induced M phase arrest, phosphorylated BMI‐1 dissociates from PRC1 and is exported to the cytoplasm via its
Banlanjo Umaru, Deepak Kumar Mishra, Shiva Senthil Kumar, Hao‐Han Pang, Brendan Devine, Komal Khan, Rachid Drissi   +6 more
wiley   +1 more source

Optimisation of a Caprylic Acid-Based Protocol for IgG Purification from Baboon (<i>Papio anubis</i>) Serum. [PDF]

Methods Protoc
Ogopotse W, Musabyimana V, Khasandi PM, Kotti D, Ngotho M, Kagira JM, Oluoch GO.   +6 more
europepmc   +1 more source

The cooperative regulation of miR‐221 by APE1 and AUF1 impacts p27Kip1 defining a miR signature relevant for cervical cancer

FEBS Open Bio, EarlyView.
A regulatory axis involving APE1, AUF1, and miR‐221 is proposed. Pri‐miR‐221 is processed by DROSHA and DICER to generate mature miR‐221, which targets p27Kip1 mRNA. APE1 and AUF1 compete for pre‐miR‐221 binding. Reduced APE1/AUF1 levels impair miR‐221 biogenesis, decrease p27Kip1 mRNA degradation, and promote cell cycle progression, chemoresistance ...
Matilde Clarissa Malfatti, Nicolò Gualandi, Gianluca Tell, Giulia Antoniali   +3 more
wiley   +1 more source

Two-stage inertial microfluidics enrichment of activated T-cells towards a bead-less chimeric antigen receptor manufacturing protocol. [PDF]

Med Oncol
Elsemary MT, Maritz MF, Smith LE, Warkiani ME, Thierry B.   +4 more
europepmc   +1 more source

Synthesis and stereochemical analysis of dynamic planar chiral oxa[7]orthocyclophene. [PDF]

Beilstein J Org Chem
Hashimoto Y, Kawasaki Y, Igawa K, Tomooka K.   +3 more
europepmc   +1 more source

Design and biological evaluation of triagonist GLP-1R/GCGR/GIPR peptides as potential therapeutic agents for diabetes and obesity. [PDF]

RSC Med Chem
Kalinowska I, Gawalska A, Kasprzycka P, Stępniewski M, Rózga P, Pałka A, Shubin A, Bukato K, Gałązka M, Burchard E, Zielińska-Świder P, Jaworski A, Feder M.   +12 more
europepmc   +1 more source